Tiffini Voss

3.7k total citations · 3 hit papers
31 papers, 2.4k citations indexed

About

Tiffini Voss is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Tiffini Voss has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Neurology and 7 papers in Physiology. Recurrent topics in Tiffini Voss's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Alzheimer's disease research and treatments (6 papers) and Neurological disorders and treatments (5 papers). Tiffini Voss is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Alzheimer's disease research and treatments (6 papers) and Neurological disorders and treatments (5 papers). Tiffini Voss collaborates with scholars based in United States, France and Belgium. Tiffini Voss's co-authors include Jeffrey L. Cummings, Michael Egan, Yuki Mukai, James Kost, Pierre N. Tariot, Bruno Vellas, Paul Aisen, Christine Furtek, Erin Mahoney and Lyn Harper Mozley and has published in prestigious journals such as New England Journal of Medicine, Brain and Neurology.

In The Last Decade

Tiffini Voss

30 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Pilot Study of Focused Ultrasound Thalamotomy for Essential Tremor

2013 650 citations W. Jeffrey Elias, Diane Huss et al. New England Journal of Medicine profile →
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

2018 471 citations Michael Egan, James Kost et al. New England Journal of Medicine profile →
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

2019 380 citations Michael Egan, James Kost et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tiffini Voss United States	16	903	604	591	433	428	31	2.4k
C. Hock Switzerland	24	1.5k 1.7×	244 0.4×	434 0.7×	937 2.2×	518 1.2×	39	3.6k
Sergey Shcherbinin United States	23	1.9k 2.1×	256 0.4×	1.1k 1.9×	609 1.4×	110 0.3×	95	3.1k
Sang Eun Kim South Korea	36	439 0.5×	686 1.1×	583 1.0×	943 2.2×	184 0.4×	162	3.4k
Stefan Förster Germany	34	629 0.7×	305 0.5×	721 1.2×	1.2k 2.8×	311 0.7×	121	3.4k
Mirosław Bryś United States	27	2.3k 2.5×	733 1.2×	1.3k 2.3×	340 0.8×	102 0.2×	47	3.9k
Jean‐Paul Soucy Canada	35	1.1k 1.3×	1.1k 1.8×	962 1.6×	551 1.3×	101 0.2×	143	3.6k
Hitoshi Shimada Japan	26	735 0.8×	627 1.0×	526 0.9×	344 0.8×	52 0.1×	138	2.2k
Yutaka Arahata Japan	17	1.2k 1.4×	702 1.2×	1.0k 1.7×	272 0.6×	64 0.1×	36	2.6k
Katharina Bürger Germany	25	1.6k 1.7×	263 0.4×	1.4k 2.5×	333 0.8×	68 0.2×	51	3.0k
Enikò Kövari Switzerland	38	1.6k 1.8×	982 1.6×	880 1.5×	353 0.8×	87 0.2×	84	4.1k

Countries citing papers authored by Tiffini Voss

Since Specialization

Citations

This map shows the geographic impact of Tiffini Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffini Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffini Voss more than expected).

Fields of papers citing papers by Tiffini Voss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffini Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffini Voss. The network helps show where Tiffini Voss may publish in the future.

Co-authorship network of co-authors of Tiffini Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffini Voss. A scholar is included among the top collaborators of Tiffini Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffini Voss. Tiffini Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mukai, Yuki, Robert Lupinacci, Stephen R. Marder, et al.. (2024). Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial. Schizophrenia Research. 270. 37–43. 10 indexed citations

Voss, Tiffini, James Kost, Christine Furtek, et al.. (2023). Progression from Prodromal Alzheimer’s Disease to Mild Alzheimer’s Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions. Journal of Alzheimer s Disease. 92(1). 341–348. 3 indexed citations

Voss, Tiffini, et al.. (2021). Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study. Pediatric Anesthesia. 32(3). 436–445. 11 indexed citations

Zhong, Wenjun, Xinyue Liu, Tiffini Voss, et al.. (2021). Medications in Patients with Dementia and Behavioral Disturbance. Journal of Alzheimer s Disease Reports. 5(1). 535–540. 6 indexed citations

Egan, Michael, Yuki Mukai, Tiffini Voss, et al.. (2019). Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease. Alzheimer s Research & Therapy. 11(1). 68–68. 63 indexed citations

Egan, Michael, James Kost, Christopher Lines, et al.. (2019). FTS3‐01‐05: FURTHER ANALYSES OF COGNITIVE OUTCOMES IN THE APECS PHASE‐3 TRIAL OF VERUBECESTAT IN PRODROMAL AD. Alzheimer s & Dementia. 15(7S_Part_17).

Egan, Michael, James Kost, Pierre N. Tariot, et al.. (2018). Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease. New England Journal of Medicine. 378(18). 1691–1703. 471 indexed citations breakdown →

Voss, Tiffini, Jerry Li, Jeffrey L. Cummings, et al.. (2018). Randomized, controlled, proof‐of‐concept trial of MK‐7622 in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 173–181. 45 indexed citations

Chou, Kelvin L., Jordan J. Elm, Catherine L. Wielinski, et al.. (2017). Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377. 137–143. 25 indexed citations

10.

Shah, Binit, Diane Huss, Tiffini Voss, et al.. (2014). Focused Ultrasound MR Guided Thalamotomy: 2 Year Follow-Up Safety And Efficacy Data (S27.005). Neurology. 82(10_supplement). 1 indexed citations

11.

Elias, W. Jeffrey, Diane Huss, Tiffini Voss, et al.. (2013). A Pilot Study of Focused Ultrasound Thalamotomy for Essential Tremor. New England Journal of Medicine. 369(7). 640–648. 650 indexed citations breakdown →

12.

Elias, W. Jeff, Diane Huss, Tiffini Voss, et al.. (2013). The use of magnetic resonance-guided high intensity focused ultrasound to treat essential tremor. The Journal of the Acoustical Society of America. 134(5_Supplement). 4090–4090. 2 indexed citations

13.

Voss, Tiffini, Daun Bahr, Jeffrey L. Cummings, et al.. (2012). Performance of a shortened Scale for Assessment of Positive Symptoms for Parkinson's disease psychosis. Parkinsonism & Related Disorders. 19(3). 295–299. 61 indexed citations

14.

Voss, Tiffini, Jordan J. Elm, Catherine L. Wielinski, et al.. (2012). Fall frequency and risk assessment in early Parkinson's disease. Parkinsonism & Related Disorders. 18(7). 837–841. 60 indexed citations

15.

Kimmelman, Jonathan, et al.. (2011). Risk of surgical delivery to deep nuclei: A meta‐analysis. Movement Disorders. 26(8). 1415–1421. 48 indexed citations

16.

Dorsey, E. Ray, Lisa M. Deuel, Tiffini Voss, et al.. (2010). Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease. Movement Disorders. 25(11). 1652–1659. 138 indexed citations

17.

Dorsey, E. Ray, Tiffini Voss, David Shprecher, et al.. (2010). A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groups. Movement Disorders. 25(13). 2128–2135. 39 indexed citations

18.

Biglan, Kevin, Tiffini Voss, Lisa M. Deuel, et al.. (2009). Telemedicine for the care of nursing home residents with Parkinson's disease. Movement Disorders. 24(7). 1073–1076. 43 indexed citations

19.

Voss, Tiffini & Bernard Ravina. (2008). Neuroprotection in Parkinson’s disease: Myth or reality?. Current Neurology and Neuroscience Reports. 8(4). 304–309. 15 indexed citations

20.

Voss, Tiffini. (2006). Field Guide to the Neurologic Examination. Neurology. 67(3). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact